Oct 13 (Reuters) - Axcella Health Inc AXLA.O :
* AXCELLA THERAPEUTICS ANNOUNCES $34.2 MILLION REGISTERED
DIRECT
OFFERING OF COMMON STOCK PRICED AT THE MARKET: APPOINTS TWO NEW
BOARD MEMBERS
* AXCELLA HEALTH INC - ENTERED AGREEMENT WITH INVESTORS IN A
REGISTERED DIRECT OFFERING OF 20,847,888 SHARES AT A PURCHASE
PRICE OF $1.64 PER SHARE
* AXCELLA HEALTH INC - INTENDS TO USE NET PROCEEDS FROM
OFFERING
TO ADVANCE LONG COVID PROGRAM
* AXCELLA HEALTH INC - ALSO INTENDS TO USE PROCEEDS TO
COMPLETE
ENROLLMENT OF ITS EMMPACT PHASE 2B CLINICAL TRIAL IN
NON-ALCOHOLIC STEATOHEPATITIS
Source text for Eikon: ID:nBwbrqVGGa
Further company coverage: AXLA.O
((Reuters.Briefs@thomsonreuters.com;))